# Study Examining PrEP-001 in Healthy Subjects

> **NCT03220048** · PHASE2 · COMPLETED · sponsor: **Hvivo** · enrollment: 66 (actual)

## Conditions studied

- Influenza A H3N2

## Interventions

- **DRUG:** PrEP-001
- **OTHER:** Placebo Comparator

## Key facts

- **NCT ID:** NCT03220048
- **Lead sponsor:** Hvivo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-16
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2019-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03220048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03220048, "Study Examining PrEP-001 in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03220048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*